Vaccitech Ltd.

Vaccitech Ltd.

Vaccitech Ltd.

Overview
Date Founded

2016

Headquarters

The Schrodinger Building,The Oxford Science Park,Heatley Road,Oxford, Oxfordshire OX4 4GA

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Other Business & Consulting Services
Pharmaceuticals
Biotechnology
Consumer Services
Medical Support Services
Hospitals & Patient Services
Holding Companies

Company Description

Vaccitech Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom.

Website

http://www.vaccitech.co.uk

In The News
GlobeNewswire
March 2, 2021
Vaccitech Appoints Two Independent Board Directors
The Daily Mail and Mail on Sunday (London)
December 27, 2020
VENTURE CAPITALIST INJECTS £10M INTO OXFORD VACCINE FIRM
GlobeNewswire
November 23, 2020
Oxford University breakthrough on global COVID-19 vaccine
RelSci
October 27, 2020
Meg Marshall is now serving in a new position at Vaccitech Ltd.
FierceBiotech
October 23, 2020
Chutes & Ladders—Kite Pharma veteran Nowers takes the helm at ONK

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Sarah Gilbert

Co-Founder

Bill Enright

Chief Executive Officer

Georgy Egorov

Chief Financial Officer

Thomas G. Evans

Chief Scientific Officer

Meg Marshall

Chief Medical Officer

Simon Alvis

Vice President Manufacturing

Board of Directors
Robin Wright

Chief Financial Officer at MiNA Therapeutics Ltd.

Karen Dawes

Founder at Knowledgeable Decisions LLC

Anne M. Phillips

Senior Vice President, Clinical Medical & Regulatory Affairs at Novo Nordisk, Inc.

Steven N. Chatfield

Former President, Emergent Product Development UK Limited & Chief Scientific Officer at Emergent BioSolutions, Inc.

Pierre Armand Morgon

Former Director at Theradiag SA

Joseph Scheeren

Independent Director at Vaccitech Ltd.

Thomas G. Evans

Chief Scientific Officer at Vaccitech Ltd.

Trending People
Central Intelligence Agency (United States)
A retiring Castro to bring younger face to Cuba's communists - The Independent UK
SolarWinds Corp.
US poised to impose sanctions Russia for cyber-attacks - BBC
Government of Afghanistan
Analysis: Biden takes a risk pulling troops from Afghanistan - The Independent UK
The Goldman Sachs Group, Inc.
Miners and oil titans lead FTSE higher - The Daily Telegraph (London)
Wells Fargo & Co.
Asian Markets Mixed In Cautious Trades - Nasdaq
Trending Organizations
Central Intelligence Agency (United States)
A retiring Castro to bring younger face to Cuba's communists - The Independent UK
SolarWinds Corp.
US poised to impose sanctions Russia for cyber-attacks - BBC
Government of Afghanistan
Analysis: Biden takes a risk pulling troops from Afghanistan - The Independent UK
The Goldman Sachs Group, Inc.
Miners and oil titans lead FTSE higher - The Daily Telegraph (London)
Wells Fargo & Co.
Asian Markets Mixed In Cautious Trades - Nasdaq
Paths to Vaccitech Ltd.
Potential Connections via
Relationship Science
You
Vaccitech Ltd.
Advisors & Consultants
Consultant
Meg Marshall

Chief Medical Officer at Vaccitech Ltd.
Investors
Details Hidden
M&G Investment Management Ltd/Private Equity

M&G Investment Management provides financing for companies located in Europe and United Kingdom. The firm provides financing for various sectors in the form of debt of underperforming, stressed or distressed investments.

Details Hidden
Future Planet Capital UK Ltd.

FCI invests in fields of technologies and life-sciences companies.

Details Hidden
Oxford Sciences Innovation Plc

Oxford Sciences Innovation Plc invests in traditional seed and follow on series a rounds in Oxford spun out companies located in the UK. It invests in companies with an investment size between £0.1 – £10 million. The firm invests in medical, industrial, data analytics, consumer tech, biotech and life sciences.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Vaccitech Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Vaccitech Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Vaccitech Ltd..